Earnings Preview — 2821 total
Lineage Cell Therapeutics heads into its May 14 earnings print riding a wall of analyst buy ratings, while the stock itself has quietly slipped 10% over the past month. The analyst community is uniformly bullish — all…
Amtech Systems reports today having nearly doubled in price over the past month — and the question into this print is whether the fundamentals can catch up with the tape. The stock's 42% one-month gain tells the…
AMKR reports Q1 2026 results today having risen 27% in the past month, but a 4% pullback in the last session suggests some investors are taking profits ahead of the release. The most striking feature of the setup is…
EC enters its Q1 2026 results today nursing a bruising month. The Colombian state oil company has lost roughly 7% over the past week and over 7% across the past month, pulling back to $13.08. Options positioning is…
Dr. Reddy's Laboratories heads into its May 14 quarterly print with options traders suddenly far more cautious than they have been all year. The clearest pre-earnings signal is the sharp turn in options positioning.…
AIDX heads into its May 15 earnings report as a study in contradictions: a fresh analyst endorsement, a borrow market that has dramatically eased, and a stock that has lost more than a quarter of its value in four…
Aktis Oncology heads into its May 15 results with a notable split: fresh institutional conviction sits alongside a short-score that remains elevated even as shorts trim positions. The lending market tells a more…
Turn Therapeutics heads into its May 14 earnings report with a quiet but telling signal: every insider trade on record points in the same direction. A cluster of buys from the Acting CFO and a director accumulated over…
Neptune Insurance Holdings Inc. heads into its May 13 earnings release on the back of a remarkable month-long re-rating — and analysts are scrambling to keep up. The stock's 25% surge over the past week tells the most…
American Bitcoin Corp. heads into its May 15 earnings release with options traders unusually bullish and short sellers sitting on a meaningful but stable position. The options picture is the clearest signal heading…
Firefly Aerospace steps into its May 13 earnings debut with short sellers quietly pulling back — even as the stock's recent surge keeps borrow conditions meaningfully tight. Short interest has pulled in roughly 4% over…
DAIC (CID HoldCo, Inc.) heads into its May 12 earnings event with the stock already pricing in distress, the Q1 numbers already public, and investors left to decide whether the headline miss changes anything. The print…
JBIO heads into its May 14 Q1 results with a wall of analyst upgrades at its back — and short sellers who spent April building positions now quietly retreating. The analyst story is unambiguous. Both Guggenheim and…
KLAR heads into its May 14 earnings report under growing short pressure — yet with options markets surprisingly calm. Short sellers have grown more committed over the past month. Short interest has climbed to 7.9% of…
USA Rare Earth, Inc. enters its maiden public-company earnings event on May 13 with a striking short-squeeze dynamic already playing out in the background — short sellers have covered aggressively even as the stock…
Amentum Holdings reports Q2 2026 earnings on May 12 with the stock already in retreat — and the debate among investors is less about short-seller pressure and more about whether the defense consultancy can rebuild…
HCAI heads into its May 15 earnings with one of the most volatile short-side stories on the Nasdaq — a borrow market running nearly nine times annualized cost, and a short position that collapsed almost as fast as it…
Summit Midstream Corporation heads into its Q1 2026 earnings report with options positioning strikingly bullish and short sellers in full retreat. The most striking signal into today's print is in options. The put/call…
WBTN heads into Wednesday's investor event with every share in the lending pool already lent out — and a Q1 print that handed shorts a mixed scorecard to work with. The lending market signals genuine short-side…
Inhibrx Biosciences heads into its May 15 earnings call sitting on a 70% one-month rally driven by clinical data — yet short sellers remain deeply embedded, setting up one of the more charged setups in small-cap…
